1,2-Cyclopentanediol, 3-(6-amino-9H-purin-9-yl)-, (1R,2S,3R)-
| Title | Journal |
|---|---|
| Synthesis of 4'-modified noraristeromycins to clarify the effect of the 4'-hydroxyl groups for inhibitory activity against S-adenosyl-L-homocysteine hydrolase. | Bioorganic & medicinal chemistry letters 20080415 |
| A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors. | Journal of virological methods 20010801 |
| Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues. | Antiviral chemistry & chemotherapy 20010701 |
| Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. | Clinical microbiology reviews 20010401 |
| S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis. | The Journal of pharmacology and experimental therapeutics 20010101 |
| Does the anti-hepatitis B virus activity of (+)-5'-noraristeromycin exist in its 4'-epimer and 4'-deoxygenated derivatives? | Journal of medicinal chemistry 19980604 |
| Carbocyclic adenosine analogues as S-adenosylhomocysteine hydrolase inhibitors and antiviral agents: recent advances. | Nucleosides & nucleotides 19980101 |
| S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation. | Molecular pharmacology 19971201 |
| Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication. | Antiviral research 19930701 |